SpringWorks Therapeutics (SWTX) Reports Q2 Loss, Tops Revenue Estimates

SpringWorks Therapeutics (SWTX) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of$ 1.12. This compares to loss of $1.25 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 51.79%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 1.17 per share when it actually produced a loss of $1.18, delivering a surprise of -0.85%. Over the last four quart ...